HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alessandro Marra Ludger Hillejan Georgios Stamatis Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marra, A. Articles by Stamatis, G. Search for Related Content PubMed Articles by Marra, A. Articles by Stamatis, G. Related Collections Lung - cancer Mediastinum Related Article

J Thorac Cardiovasc Surg 2008;135:843-849
© 2008 The American Association for Thoracic Surgery

General Thoracic Surgery

Remediastinoscopy in restaging of lung cancer after induction therapy

^a Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen, Germany
^b Department of Thoracic Surgery, Klinikum St Georg, Ostercappeln, Germany

Received for publication June 10, 2007; revisions received June 10, 2007; accepted for publication July 30, 2007.

^_* Address for reprints: Alessandro Marra, MD, Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Tüschener Weg 40, D-45239 Essen, Germany. (Email: alexmarra{at}yahoo.it).

Objectives: The aim of the present study was to evaluate the feasibility and diagnostic value of repeat mediastinoscopy as part of the response-evaluation protocol of 2 phase II multimodality studies for either stage IIIA/B non–small cell lung cancer or small cell lung cancer.

Methods: From January 1991 through December 1998, 104 patients (79 men and 25 women) with stage IIIA/B non–small cell lung cancer (84 patients) or small cell lung cancer (17 patients) were enrolled in 2 different multimodality trials and underwent remediastinoscopy after induction chemoradiotherapy. The median age was 56 years (range, 34–72 years). Sensitivity, specificity, accuracy, and predictive values of remediastinoscopy were calculated by using standard definitions.

Results: Remediastinoscopy was feasible in 98% of cases. Mortality was nil, and morbidity very low (1.9%). Lymph node downstaging (N0) was observed in 84 patients, persisting N2 disease was observed in 15 patients, and N3 disease was observed in 5 patients. Sensitivity was 61%, specificity was 100%, and accuracy was 88%. Positive predictive and negative predictive values reached 100% and 85%, respectively. According to the results of remediastinoscopy, 81 patients underwent surgical intervention, 3 refused the operation, and an unnecessary thoracotomy could be avoided in the remaining 20.

Conclusions: Remediastinoscopy provides a histologic proof of mediastinal downstaging with high diagnostic accuracy, is technically feasible with low morbidity, and still remains a valuable tool, even in an era of highly sophisticated imaging and endoscopic procedures. Persisting nodal disease at repeat mediastinoscopy carries a poor survival in the majority of cases because of occult metastases, so that indication for surgical intervention in such an unfavorable group of patients should be evaluated very carefully.

Related Article

Reference values: No need for confusion

Nancy A. Obuchowski
J. Thorac. Cardiovasc. Surg. 2009 137: 1572-1573. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				N. A. Obuchowski Reference values: No need for confusion. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1572 - 1573. [Full Text] [PDF]

				E. Lim and M. Dusmet Remediastinoscopy: a statistical reinterpretation. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 254 - 255. [Full Text] [PDF]

				T. W. Rice and E. H. Blackstone Referent values and equipoise: editors' notes. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 256 - 257. [Full Text] [PDF]